Rare Cancer News & Clinical Trials » Trial

Trial - Adrenal Cancer (100 unread)

1 2

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Posted: November 21st, 2023, 3:00am GMT

Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor
Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Sponsors: Shanghai Jiao Tong University School of Medicine
Not yet recruiting
Metastasis-directed Therapy for Oligometastases of Breast Cancer

Posted: November 16th, 2023, 3:00am GMT

Conditions: Breast Cancer; Oligometastasis; Metastatic Breast Cancer
Interventions: Drug: Systemic therapy for 12 weeks after primary registration; Procedure: Radiation therapy (SBRT/conventional RT); Procedure: Surgery; Drug: Same systemic therapy after secondary registration
Sponsors: Tokyo Medical and Dental University
Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Posted: November 15th, 2023, 3:00am GMT

Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Posted: November 9th, 2023, 3:00am GMT

Conditions: Extensive Small Cell Lung Cancer
Interventions: Drug: Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
Sponsors: Qianfoshan Hospital
Recruiting
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

Posted: October 25th, 2023, 2:00am GMT

Conditions: Primary Aldosteronism Due to Aldosterone Producing Adenoma; Primary Aldosteronism; Adrenal Tumors
Interventions: Combination Product: 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
Sponsors: Changi General Hospital; National University Health System, Singapore; Clinical Imaging Research Centre; Singapore General Hospital; Tan Tock Seng Hospital; Khoo Teck Puat Hospital; Ng Teng Fong General Hospital; Sengkang General Hospital
Recruiting
Skin Ion and Water Content in Human HYpertension (SKIWHY)

Posted: October 19th, 2023, 2:00am GMT

Conditions: Hyperaldosteronism; Hypertension; Aldosterone-producing Adenoma; Aldosteronism; Aldosterone Disorder; Essential Hypertension; Bilateral Adrenal Hyperplasia; Conn Adenoma
Interventions: Procedure: Skin Biopsy; Procedure: Video-laparoscopic adrenalectomy
Sponsors: University Hospital Padova
Recruiting
Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer

Posted: October 5th, 2023, 2:00am GMT

Conditions: Thyroid Cancer, Papillary; Primary Aldosteronism
Interventions: Diagnostic Test: Secreening test for primary aldosteronism and Confirmatory Testing
Sponsors: Instituto do Cancer do Estado de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Posted: October 4th, 2023, 2:00am GMT

Conditions: Adrenocortical Carcinoma; ACC; Metastatic Adrenocortical Carcinoma
Interventions: Radiation: Ablative Radiotherapy; Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
National Registry of Rare Kidney Diseases

Posted: October 4th, 2023, 2:00am GMT

Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Denys-Drash Syndrome; Dominant Hypophosphataemia With Nephrolithiasis and/or Osteoporosis; Drug Induced Fanconi Syndrome; Drug-Induced Hypomagnesemia; Drug-Induced Nephrogenic Diabetes Insipidus; Epilepsy, Ataxia, Sensorineural Deafness and Tubulopathy; Fabry Disease; Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis; Familial Primary Hypomagnesemia With Hypocalcuria; Familial Primary Hypomagnesaemia With Normocalciuria; Familial Renal Glucosuria; Fanconi Renotubular Syndrome 1; Fanconi Renotubular Syndrome 2; Fanconi Renotubular Syndrome 3; Fibrillary Glomerulonephritis; Fibromuscular Dysplasia; Focal Segmental Glomerulosclerosis; Generalised Pseudohypoaldosteronism Type 1; Gitelman Syndrome; Heavy-Metal-Induced Fanconi Syndrome; Hepatocyte Nuclear Factor 1-Beta-Associated Monogenic Diabetes; Hereditary Renal Hypouricemia; Hereditary Hypophosphatemic Rickets With Hypercalciuria; Hyperuricaemic Nephropathy; IgA Nephropathy; Immunotactoid Glomerulonephritis With Organised Microtubular Mononoclonal Immunoglobulin Deposits; Inherited Renal Cancer Syndromes; Intracapillary Monoclonal IgM Without Cryoglobulin; Intraglomerular/Capillary Lymphoma/Leukaemia; Isolated Autosomal Dominant Hypomagnesaemia Glaudemans Type; Liddle Syndrome; Light Chain Cast Nephropathy; Light Chain Proximal Tubulopathy Without Crystals; Light Chain Proximal Tubulopathy With Crystals; Lowe Syndrome; Membranous Nephropathy; Membranoproliferative Glomerulonephritis; Medullary Cystic Kidney Disease; Minimal Change Nephropathy; Mitochondrial Disease Of The Kidney; Monoclonal Immunoglobulin Deposition Disease; Nail Patella Syndrome; Nephrogenic Diabetes Insipidus; Nephrogenic Syndrome of Inappropriate Antidiuresis; Nephronophthisis; Primary Hypomagnesemia With Secondary Hypocalcemia; Primary Hyperoxaluria; Proliferative Glomerulonephritis With Monoclonal IgG Deposits; Proximal Tubulopathy Without Crystals; Pseudohypoaldosteronism Type 1, 2A-2E; Pure Red Cell Aplasia; Retroperitoneal Fibrosis; Sickle Cell Nephropathy; Shiga Toxin Associated Haemolytic Uraemic Syndrome; Steroid Resistant Nephrotic Syndrome; Steroid-Sensitive Nephrotic Syndrome; Thin Basement Membrane Nephropathy; Thrombotic Microangiopathy With Monoclonal Gammopathy; Type 1 Cryoglobulinaemic Glomerulonephritis; Tuberous Sclerosis; Unclassified Monoclonal Gammopathy Of Renal Significance; Vasculitis
Sponsors: UK Kidney Association
Recruiting
Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma

Posted: October 2nd, 2023, 2:00am GMT

Conditions: Pheochromocytoma; Non-Secretory Adrenal Adenoma
Interventions: Procedure: adrenalectomy
Sponsors: Central Hospital, Nancy, France
Recruiting
Tranexamic Acid in Nasal Mohs Reconstruction

Posted: September 27th, 2023, 2:00am GMT

Conditions: Postoperative Bleeding; Skin Cancer Face
Interventions: Drug: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine); Drug: Control (1% lidocaine with 1:100,000 epinephrine)
Sponsors: Vanderbilt University Medical Center
Not yet recruiting
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Posted: September 27th, 2023, 2:00am GMT

Conditions: Neuroendocrine Tumors
Interventions: Diagnostic Test: Al18F-NOTA-LM3; Diagnostic Test: 68Ga-DOTATATE; Diagnostic Test: Al18F-NOTA-LM3; Diagnostic Test: 68Ga-NODAGA-LM3
Sponsors: Peking Union Medical College Hospital
Recruiting
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Posted: September 22nd, 2023, 2:00pm GMT

Conditions: Adrenal Tumor; Adrenal Disease; Adrenal Mass; Adrenalectomy; Status; Adrenal Hyperplasia; Adrenal Gland Metastasis; Adrenal Cortex Diseases; Pheochromocytoma; Cushing Syndrome; Conn Adenoma; Adrenocortical Carcinoma; Adrenocortical Adenoma; Adrenocortical Tumor
Sponsors: University Hospital Olomouc; University Hospital Ostrava; Tomas Bata Hospital, Czech Republic; General University Hospital, Prague; University Hospital Hradec Kralove
Recruiting
Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Posted: September 18th, 2023, 2:00pm GMT

Conditions: Neuroendocrine Carcinomas; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical
Interventions: Drug: ADCT-701
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
The Effects of Sufentanil-remimazolam vs. Remifentanil-remimazolam Total Intravenous Anesthesia on Postoperative Pain in Laparoscopic-assisted Gastrectomy

Posted: September 14th, 2023, 2:00am GMT

Conditions: Pheochromocytoma
Interventions: Drug: dexmedetomidine; Drug: 0.9% normal saline
Sponsors: Yonsei University
Completed
MT2022-01: MSCs for ALD

Posted: September 11th, 2023, 2:00am GMT

Conditions: Cerebral Adrenoleukodystrophy
Interventions: Biological: Mesenchymal stem cells (IV-MSC)
Sponsors: Masonic Cancer Center, University of Minnesota
Recruiting
Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults

Posted: September 8th, 2023, 2:00am GMT

Conditions: Chronic Low-back Pain; Older Adults; Core Stabilization Exercise Therapy
Interventions: Behavioral: core stabilization exercise
Sponsors: The Hong Kong Polytechnic University
Recruiting
Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial

Posted: September 6th, 2023, 2:00pm GMT

Conditions: Breast Neoplasms
Interventions: Procedure: Cold dissection; Procedure: Electrocautery Dissection
Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours

Posted: August 28th, 2023, 2:00pm GMT

Conditions: Hypopituitarism; Radiotherapy-Induced Hypopituitarism; Brain Tumor
Intervention: Diagnostic Test: Dynamic testing of Pituitary Function
Sponsors: Royal College of Surgeons, Ireland; Beaumont Hospital
Not yet recruiting
Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Posted: August 23rd, 2023, 2:00pm GMT

Conditions: Locally Advanced Adrenal Cortex Carcinoma; Adrenal Cortical Carcinoma; Stage III Adrenal Cortex Carcinoma; Stage IV Adrenal Cortex Carcinoma AJCC v8; Unresectable Adrenal Cortex Carcinoma
Interventions: Biological: Atezolizumab; Procedure: Biospecimen Collection; Drug: Cabozantinib S-malate; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
Effect of Acetaminophen Preemptive Analgesia on Postoperative Cognitive Function

Posted: August 22nd, 2023, 2:00pm GMT

Condition: Cognitive Function
Interventions: Drug: acetaminophen mannitol; Drug: Normal saline
Sponsor: Affiliated Hospital of Nantong University
Recruiting
Phase 1 Study of 68Ga-R8760

Posted: August 21st, 2023, 2:00am GMT

Conditions: Adrenocortical Carcinoma
Interventions: Drug: 68Ga-R8760 injection at pre-defined dose levels; Drug: 68Ga-R8760 injection
Sponsors: Radionetics Oncology
Recruiting
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss

Posted: August 14th, 2023, 2:00am GMT

Conditions: Uterine Fibroid
Interventions: Drug: Carbetocin
Sponsors: Egymedicalpedia
Completed
$Permalink for 'Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies'$
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies

Posted: August 8th, 2023, 2:00pm GMT

Conditions: Recurrent Multiple Myeloma; Refractory Multiple Myeloma
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Echocardiography; Biological: Elotuzumab; Procedure: Magnetic Resonance Imaging; Biological: Mezigdomide; Procedure: X-Ray Imaging
Sponsors: Abdullah Khan
Recruiting
Engaging Black Men in Colorectal Cancer Screening

Posted: August 7th, 2023, 2:00pm GMT

Conditions: Colorectal Cancer; CRC; Behavior
Intervention: Behavioral: mHealth Application
Sponsors: Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting
Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome

Posted: August 1st, 2023, 2:00am GMT

Conditions: Stellate Ganglion Block; Cervical Epidural; Complex Regional Pain Syndromes
Interventions: Drug: Ultrasound guided Stellate ganglion block; Drug: unilateral cervical epidural
Sponsors: Tanta University
Recruiting
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Posted: July 19th, 2023, 2:00am GMT

Conditions: Polycystic Ovary Syndrome; Obesity; Infertility, Female
Interventions: Drug: Liraglutide + Metformin; Drug: Metformin
Sponsors: Mỹ Đức Hospital
Not yet recruiting
LRAMPS Versus LDP in Early-stage Left-sided Pancreatic Cancer Within Fudan Criteria

Posted: July 11th, 2023, 2:00pm GMT

Conditions: Left-sided Pancreatic Cancer
Interventions: Procedure: LRAMPS; Procedure: LDP
Sponsors: Fudan University; The Third Affiliated Hospital of Soochow University; Qilu Hospital of Shandong University
Recruiting
Minimally Invasive Esophagectomy Pain Control Trial

Posted: June 15th, 2023, 2:00pm GMT

Conditions: Postoperative Pain, Acute; Postoperative Complications
Interventions: Procedure: Thoracic epidural catheter; Procedure: Local intercostal nerve block; Procedure: Cryo-analgesia and intercostal nerve block; Procedure: Serratus plane catheter blocks and intercostal nerve blocks
Sponsor: Swedish Medical Center
Recruiting
Intercostal Cryoanalgesia for Acute Pain After VATS Lung Resection

Posted: June 9th, 2023, 2:00pm GMT

Conditions: Thoracic Surgery; Video-Assisted; Cryotherapy Effect; Paravertebral Block
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection

Posted: June 1st, 2023, 2:00pm GMT

Conditions: Cryotherapy Effect; Chronic Pain; Lung Cancer; Surgery
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

Posted: May 23rd, 2023, 2:00pm GMT

Conditions: Hepatocellular Carcinoma
Interventions: Diagnostic Test: 18F-FDGal PET/CT or PET/MRI
Sponsors: University of Aarhus
Recruiting
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Posted: May 2nd, 2023, 2:00pm GMT

Condition: Aldosterone-Producing Adenoma
Intervention: Diagnostic Test: CXCR4
Sponsor: Zhongnan Hospital
Recruiting
Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers

Posted: April 28th, 2023, 2:00pm GMT

Conditions: Squamous Cell Carcinoma of the Head and Neck; Paclitaxel; Carboplatin; Nivolumab
Intervention: Drug: GCP intratumoral catheter
Sponsor: Centre Hospitalier Universitaire, Amiens
Not yet recruiting
Ramadan Fasting in Secondary Adrenal Insufficiency Patients

Posted: April 25th, 2023, 2:00am GMT

Conditions: Secondary Adrenal Insufficiency; Fasting, Intermittent
Interventions: Behavioral: education and drug adjustement
Sponsors: Hopital La Rabta
Active, not recruiting
Colonoscopic Sucralfate Spray in Prevention of Delayed Polypectomy Bleeding

Posted: April 18th, 2023, 2:00pm GMT

Conditions: Bleeding
Interventions: Drug: Sucralfate
Sponsors: National Cheng-Kung University Hospital
Recruiting
Methods Decreasing Bleeding in Open Myomectomy

Posted: April 10th, 2023, 2:00pm GMT

Conditions: Misoprostol Allergy; Oxytocin Allergy; Tranexamic Acid Allergy; Ethamsylate Allergy; Myoma; Blood Loss, Surgical
Interventions: Drug: Misoprostol; Device: Tourniquet; Drug: Carbetocin; Drug: Oxytocin; Drug: combined TXA and ethamsylate; Drug: Vasopressin; Drug: Bupivacaine Hydrochloride 0.5 % Injectable Solution epinephrine
Sponsor: Cairo University
Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Posted: April 7th, 2023, 2:00am GMT

Conditions: Cushing Syndrome; Cushing Disease; Ectopic ACTH Syndrome
Interventions: Drug: CRN04894
Sponsors: Crinetics Pharmaceuticals Inc.
Recruiting
PADUA PREDICTION SCORE in Cirrhotic Patients

Posted: March 29th, 2023, 2:00pm GMT

Condition: Portal Thrombosis
Intervention:
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions

Posted: March 24th, 2023, 2:00pm GMT

Conditions: Patient With Radiotherapy (Linac MRI); Mobile Cancerous Lesion
Interventions: Combination Product: With non-magnetic screen
Sponsors: Centre Georges Francois Leclerc
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Posted: March 24th, 2023, 2:00pm GMT

Conditions: Oligometastatic Disease; Oligoprogression; Toxicity Due to Radiotherapy; Quality of Life
Interventions: Radiation: Single fraction SABR; Radiation: Multiple fraction SABR; Other: QoL reporting alone; Other: QoL reporting, symptom screen and healthcare provider intervention
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada
Not yet recruiting
Use of Virtual Reality for Surgical Planning in Neuroblastoma

Posted: March 23rd, 2023, 2:00pm GMT

Condition: Neuroblastoma
Interventions: Other: Immersive virtual reality imaging; Other: Gold standard imaging
Sponsor: Hospital Sant Joan de Deu
Recruiting
European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma

Posted: March 10th, 2023, 3:00pm GMT

Condition: Adrenocortical Carcinoma
Intervention: Procedure: Adrenalectomy with or without lymphadenectomy
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

Posted: March 6th, 2023, 3:00pm GMT

Conditions: Cancer; Adrenal
Interventions: Other: Blood sample; Other: Urine sample; Other: Tumor sample
Sponsors: Assistance Publique - Hôpitaux de Paris; National Cancer Institute, France
Not yet recruiting
Improving Cancer Screening and Follow-up in Community Health Centers

Posted: March 6th, 2023, 3:00pm GMT

Conditions: Breast Cancer Screening; Colorectal Cancer Screening; Implementation
Intervention: Other: Practice-Level Implementation Strategies
Sponsors: Harvard School of Public Health (HSPH); National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer or Metastases (LTLR-LC)

Posted: March 1st, 2023, 3:00pm GMT

Conditions: Liver Transplant Disorder; Hepatic Cancer; End-stage Liver Disease
Intervention: Procedure: assisted liver transplantation combined with two-stage hepatectomy
Sponsors: RenJi Hospital; The Affiliated Hospital of Qingdao University; The First Affiliated Hospital of Zhengzhou University
Not yet recruiting
Effect of Sleep Disorder on the Development of Lung Tumors

Posted: February 27th, 2023, 3:00pm GMT

Condition: Sleep Disorder, Lung Tumor
Intervention:
Sponsor: RenJi Hospital
Not yet recruiting
Cohort Study of Adrenogenic Autonomic Cortisol Secretion

Posted: February 24th, 2023, 3:00pm GMT

Conditions: Diagnosis; Treatment; Adrenogenic Autonomic Cortisol Secretion
Intervention:
Sponsor: Chongqing Medical University
Not yet recruiting
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery

Posted: February 22nd, 2023, 3:00pm GMT

Conditions: Renal Cell Carcinoma; Adrenal Tumor; Nonfunctioning Kidney; Renal Pelvis Carcinoma; Ureteral Tumor; Bladder Cancer; Prostate Cancer; Pelvic Tumor; Renal Cyst; Duplex Kidney; Renal Calculi; Ureteral Calculi; Ureteropelvic Junction Obstruction; Penile Cancer
Intervention: Device: telesurgery by domestic surgical robot
Sponsor: The Affiliated Hospital of Qingdao University
Recruiting
Tranexamic Acid During Upper GI Endoscopic Resection Procedures

Posted: January 18th, 2023, 3:00pm GMT

Conditions: Gastric Polyp; Gastric Neoplasm; Duodenal Neoplasms; Esophageal Neoplasms
Interventions: Drug: Tranexamic acid; Drug: Epinephrine injection
Sponsor: Assaf-Harofeh Medical Center
Recruiting
Baby Detect : Genomic Newborn Screening

Posted: January 18th, 2023, 3:00am GMT

Conditions: Congenital Adrenal Hyperplasia; Familial Hyperinsulinemic Hypoglycemia 1; Phosphoglucomutase 1 Deficiency; Maturity Onset Diabetes of the Young; Cystic Fibrosis; Hypophosphatasia, Infantile; Congenital Hypothyroidism; Deficit in Anterior Pituitary Function and Variable Immunodeficiency; Pituitary Hormone Deficiency, Combined; Diamond Blackfan Anemia; Wiskott-Aldrich Syndrome; Fanconi Anemia; Hemophilia A; Hemophilia B; Glucose 6 Phosphate Dehydrogenase Deficiency; Alpha-Thalassemia; Sickle Cell Disease; Shwachman-Diamond Syndrome; Alpha 1-Antitrypsin Deficiency; Inflammatory Bowel Disease 25, Autosomal Recessive; Wilson Disease; Progressive Familial Intrahepatic Cholestasis; Crigler-Najjar Syndrome; Familial Chylomicronemia; Lysosomal Acid Lipase Deficiency; Familial Hemophagocytic Lymphocytosis; Griscelli Syndrome; Chediak-Higashi Syndrome; Severe Congenital Neutropenia; Severe Combined Immune Deficiency; Chronic Granulomatous Disease; Menkes Disease; Adrenoleukodystrophy; Smith-Lemli-Opitz Syndrome; Ataxia With Vitamin E Deficiency; Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type); Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type); Thiamine-Responsive Megaloblastic Anemia; Thiamine Metabolism Dysfunction Syndrome 2; Deficiency of GOT2; Cerebral Folate Transport Deficiency; Segawa Syndrome, Autosomal Recessive; Congenital Myasthenic Syndrome; Metachromatic Leukodystrophy; Sepiapterin Reductase Deficiency; Dopamine Beta Hydroxylase Deficiency; Glut1 Deficiency Syndrome; Late-Infantile Neuronal Ceroid Lipofuscinosis; Aromatic L-amino Acid Decarboxylase Deficiency; Charcot-Marie-Tooth Disease, Type 6C; Hereditary Hyperekplexia; Brain Dopamine-Serotonin Vesicular Transport Disease; Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency; Tyrosinemia, Type I; Disaccharide Intolerance I; Beta Ketothiolase Deficiency; Phosphoglycerate Dehydrogenase Deficiency; Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency; Pyridoxine-5'-Phosphate Oxidase Deficiency; Pyridoxine-Dependent Epilepsy; Propionic Acidemia; Pompe Disease; Phenylalanine Hydroxylase Deficiency; Ornithine Transcarbamylase Deficiency; N Acetyl Glutamate Synthetase Deficiency; Riboflavin Deficiency; Maple Syrup Urine Disease; Medium Chain Acyl CoA Dehydrogenase Deficiency; Malonic Acidemia; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Isovaleric Acidemia; Phosphoserine Aminotransferase Deficiency; Phosphoserine Phosphatase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria; S-Adenosylhomocysteine Hydrolase Deficiency; Mucopolysaccharidosis VII; Mucopolysaccharidosis VI; Mucopolysaccharidosis IV A; Mucopolysaccharidosis II; Mucopolysaccharidosis I; Transcobalamin Deficiency; Isolated Methylmalonic Acidemia; Cobalamin Deficiency; Homocystinuria; Holocarboxylase Synthetase Deficiency; Fanconi Bickel Syndrome; Glycogen Storage Disease; Glycine Encephalopathy; Glutaric Acidemia I; Glucose Galactose Malabsorption; Gaucher Disease, Type 1; Galactosemias; Fructosemia; Fructose-1,6-Diphosphatase Deficiency; Carbamoyl Phosphate Synthase 1 Deficiency; Citrullinemia Type II; Citrullinemia 1; Creatine Deficiency Syndrome; Systemic Primary Carnitine Deficiency; Carnitine Palmitoyltransferase Deficiency 2; Carnitine Palmitoyltransferase Deficiency 1; Carnitine Acylcarnitine Translocase Deficiency; Riboflavin Transporter Deficiency; Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency; Andersen Tawil Syndrome; Timothy Syndrome; Jervell-Lange Nielsen Syndrome; Catecholaminergic Polymorphic Ventricular Tachycardia; Familial Hypertrophic Cardiomyopathy Type 4; Pseudohypoaldosteronism, Type II; Pseudohypoaldosteronism Type 1; Primary Hyperoxaluria; X Linked Hypophosphatemia; Hereditary Nephrogenic Diabetes Insipidus; Cystinosis; Congenital Nephrotic Syndrome, Finnish Type; Alport Syndrome; Hereditary Retinoblastoma; Biotinidase Deficiency; Aciduria, Argininosuccinic; Argininemia; Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of; 3-Hydroxy 3-Methyl Glutaric Aciduria; 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency
Sponsors: Centre Hospitalier Régional de la Citadelle; Centre Hospitalier Universitaire de Liege; University of Liege; Sanofi; Orchard Therapeutics; Takeda; Zentech-Lacar Company; Leon Fredericq Foundation
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Posted: December 2nd, 2022, 3:00am GMT

Conditions: Adrenocortical Carcinoma
Interventions: Drug: Mitotane; Drug: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Posted: September 10th, 2022, 2:00am GMT

Conditions: Medulloblastoma
Interventions: Procedure: Surgical resection; Procedure: Ommaya/VPS; Drug: Methotrexate; Drug: Cisplatin; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Topotecan; Drug: Etoposide; Drug: Pegfilgrastim; Drug: Filgrastim; Radiation: Irradiation; Other: Educational and Media Intervention; Other: SOC, Educational and Media Intervention
Sponsors: St. Jude Children's Research Hospital
Recruiting
Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults

Posted: July 19th, 2022, 2:00am GMT

Conditions: Craniopharyngioma, Child; Craniopharyngioma; Recurrent Craniopharyngioma
Interventions: Drug: Nivolumab; Drug: DAY101
Sponsors: Sabine Mueller, MD, PhD; Bristol-Myers Squibb; Day One Biopharmaceuticals, Inc.
Recruiting
Metabolic Myopathy in Endocrinopathy

Posted: July 13th, 2022, 2:00am GMT

Conditions: Cushing Syndrome; Pheochromocytoma; Conns Syndrome; Metabolic Myopathy
Interventions: Procedure: Muscle biopsy
Sponsors: Barts & The London NHS Trust; Imperial College London; Queen Mary University of London
Terminated
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Posted: July 7th, 2022, 2:00pm GMT

Conditions: Primary Aldosteronism; Adrenal Cushing Syndrome; Pheochromocytoma; Endocrine Neoplasia
Interventions: Diagnostic Test: Adrenal aldosterone synthase (CYP11B2) staining; Diagnostic Test: Adrenal cortisol synthase (CYP11B1) staining; Diagnostic Test: Histopathological analysis
Sponsors: Helsinki University Central Hospital; Finnish Institute for Health and Welfare; University of Helsinki; Tampere University Hospital; Tampere University
Recruiting
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor

Posted: June 29th, 2022, 2:00pm GMT

Conditions: Autonomous Cortisol Secretion (ACS); ACTH-Independent Cushing Syndrome; ACTH-Independent Adrenal Cushing Syndrome, Somatic
Interventions: Drug: SPI-62 dose1; Drug: SPI-62 dose 2; Drug: SPI-62 dose 3; Drug: SPI-62 dose 4; Drug: Placebo
Sponsors: Sparrow Pharmaceuticals
Recruiting
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Posted: May 11th, 2022, 2:00am GMT

Conditions: Polycystic Ovary Syndrome
Interventions: Drug: Tildacerfont; Drug: Placebo
Sponsors: Spruce Biosciences
Completed
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Posted: May 10th, 2022, 2:00pm GMT

Conditions: Primary Aldosteronism; Aldosterone-Producing Adenoma
Interventions: Procedure: EUS-RFA of left adrenal gland; Procedure: adrenalectomy
Sponsors: Haukeland University Hospital
Recruiting
Tranexamic Acid During Colonic Endoscopic Resection Procedures

Posted: April 26th, 2022, 2:00pm GMT

Condition: Colon Neoplasm
Interventions: Drug: Tranexamic acid; Drug: Standard
Sponsor: Assaf-Harofeh Medical Center
Recruiting
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

Posted: April 26th, 2022, 2:00pm GMT

Condition: Cancer
Intervention: Behavioral: Survivorship Care Plan-Personal Health Record (SCP-PHR)
Sponsors: Indiana University; National Cancer Institute (NCI)
Recruiting
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

Posted: April 1st, 2022, 2:00am GMT

Conditions: Cushing's Syndrome I; Cushing Disease Due to Increased ACTH Secretion; Cortisol Excess; Cortisol; Hypersecretion; Cortisol Overproduction; Ectopic ACTH Secretion
Interventions: Drug: SPI-62; Drug: Placebo
Sponsors: Sparrow Pharmaceuticals
Recruiting
TAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction

Posted: March 29th, 2022, 2:00am GMT

Conditions: Breast Cancer
Interventions: Procedure: TAP block; Procedure: QL Block
Sponsors: Ottawa Hospital Research Institute
Withdrawn
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Posted: February 14th, 2022, 3:00pm GMT

Conditions: Neuroendocrine Tumors; Carcinoma, Neuroendocrine
Sponsors: National Cancer Institute (NCI)
Recruiting
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Posted: January 20th, 2022, 3:00pm GMT

Condition: Solid Tumors With PTCH1 Loss-of-function Mutations
Intervention: Drug: ENV-101 (taladegib)
Sponsor: Endeavor Biomedicines, Inc.
Recruiting
Real-time Ultrasound Guidance for Thoracic Epidural Blocks

Posted: December 21st, 2021, 3:00pm GMT

Conditions: Analgesia; Thoracic Tumors; Abdomen Tumors; Rib Fractures
Intervention: Procedure: Real-time ultrasound guidance for thoracic epidural catheter placement.
Sponsor: University of Chile
Not yet recruiting
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients >= 18 Years Old With Advanced Stage Rare Cancers, RARE 2 Study

Posted: December 2nd, 2021, 3:00pm GMT

Conditions: Adrenal Gland Pheochromocytoma; Hematopoietic and Lymphoid System Neoplasm; Malignant Solid Neoplasm; Paraganglioma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Talazoparib; Drug: Temozolomide
Sponsors: National Cancer Institute (NCI)
Recruiting
21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial

Posted: November 23rd, 2021, 3:00pm GMT

Condition: Breast Cancer Female
Intervention: Procedure: Supine MRI
Sponsors: Dartmouth-Hitchcock Medical Center; CairnSurgical, Inc.
Recruiting
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma

Posted: September 5th, 2021, 2:00am GMT

Conditions: Adrenocortical Carcinoma
Interventions: Drug: Pembrolizumab / Lenvatinib
Sponsors: National Cancer Center, Korea; MSD Korea Ltd.
Enrolling by invitation
Milademetan in Advanced/Metastatic Solid Tumors

Posted: August 19th, 2021, 2:00pm GMT

Conditions: Solid Tumors; Head and Neck Carcinoma; Cholangiocarcinoma; Sarcoma; Lung Adenocarcinoma; Bladder Urothelial Carcinoma; Stomach Adenocarcinoma; Breast Cancer Invasive; Ovarian Carcinoma; Cervical Cancer; Non Small Cell Lung Cancer; Gastric Cancer; Biliary Tract Cancer; Melanoma; Pancreas Cancer; MDM2 Gene Amplification; Testicular Germ Cell Tumor; Adrenocortical Carcinoma
Interventions: Drug: RAIN-32
Sponsors: Rain Oncology Inc
Terminated
Feasibility of 2 Interventions to Reduce Fatigue in Patients With Chemotherapy for Metastatic Colorectal Cancer

Posted: August 10th, 2021, 2:00pm GMT

Condition: Colorectal Cancer Metastatic
Interventions: Behavioral: Hypnosis; Behavioral: CBT
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Recruiting
Telehealth-Filter Ventilation ( COMET2P1 )

Posted: July 21st, 2021, 2:00pm GMT

Condition: Tobacco Use
Interventions: Other: Ventilated Cigarette Filter; Other: Unventilated Cigarette Filter
Sponsors: Masonic Cancer Center, University of Minnesota; Ohio State University
Recruiting
Tumescence in HNC Skin Graft Reconstruction

Posted: July 19th, 2021, 2:00pm GMT

Conditions: Head and Neck Cancer; Surgery--Complications; Graft Failure
Intervention: Procedure: Tumescence During STSG Harvest
Sponsor: University of California, Davis
Recruiting
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction

Posted: June 25th, 2021, 2:00pm GMT

Condition: Metastatic Carcinoma
Intervention: Radiation: Stereotactic ablative body radiation therapy
Sponsors: Baptist Health South Florida; Viewray Inc.
Recruiting
3D Laparoscopic Adrenalectomies for Adrenal Tumors

Posted: May 28th, 2021, 2:00am GMT

Conditions: Adrenal Tumor; Adrenalectomy; Status
Sponsors: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Posted: May 21st, 2021, 2:00pm GMT

Conditions: Pediatric Solid Tumor; Osteosarcoma; Rhabdomyosarcoma; Neuroblastoma; Ewing Sarcoma; Wilms Tumor; Adrenocortical Cancer; Desmoplastic Small Round Cell Tumor; Germ Cell Cancer; Rhabdoid Tumor; Clear Cell Sarcoma; Hepatoblastoma; Melanoma; Carcinoma; Malignant Peripheral Nerve Sheath Tumors; Soft Tissue Sarcoma
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MESNA; Drug: B7-H3 CAR T cells
Sponsor: St. Jude Children's Research Hospital
Recruiting
The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Posted: April 27th, 2021, 2:00pm GMT

Conditions: Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Pheochromocytoma, Metastatic; Paraganglioma, Malignant; Paraganglioma, Extra-Adrenal
Intervention: Drug: anlotinib hydrochloride
Sponsor: Peking Union Medical College Hospital
Recruiting
Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

Posted: March 9th, 2021, 3:00pm GMT

Conditions: Paraganglioma; Pheochromocytoma; Genetic Predisposition to Disease; Pathology; Somatic Mutation; Head and Neck Cancer; Neuroendocrine Tumors
Intervention:
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Posted: March 5th, 2021, 3:00am GMT

Conditions: Advanced Lung Carcinoma; Advanced Malignant Solid Neoplasm; Malignant Adrenal Gland Neoplasm; Metastatic Liver Carcinoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Stage III Liver Cancer; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Liver Cancer; Stage IV Lung Cancer AJCC v8; Stage IVA Liver Cancer; Stage IVA Lung Cancer AJCC v8; Stage IVB Liver Cancer; Stage IVB Lung Cancer AJCC v8
Interventions: Biological: Anti-CTLA4 Monoclonal Antibody BMS-986218; Biological: Nivolumab; Radiation: Stereotactic Body Radiation Therapy
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Posted: March 1st, 2021, 3:00pm GMT

Condition: Smoldering Plasma Cell Myeloma
Interventions: Drug: Dexamethasone; Drug: Iberdomide Hydrochloride; Other: Quality-of-Life Assessment
Sponsors: Emory University; Bristol-Myers Squibb; National Cancer Institute (NCI)
Recruiting
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.

Posted: February 5th, 2021, 3:00pm GMT

Conditions: Breast Cancer; Lung Cancer; Colon Cancer; Solid Tumor, Adult
Interventions: Behavioral: PEPRR; Behavioral: Pep-Pal
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI)
Recruiting
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract

Posted: November 5th, 2020, 3:00pm GMT

Conditions: Urothelial Carcinoma; Cancer
Intervention: Drug: Patients receiving neoadjuvant therapy before radical nephrectomy
Sponsors: Centre Hospitalier Universitaire de Nīmes; Pitié-Salpêtrière Hospital; Hôpital Bichat-Claude Bernard, 75018 Paris; Hopital Foch 92151 Suresnes; Institut Paoli-Calmettes; European Georges Pompidou Hospital; Saint-Louis Hospital, Paris, France; Centre Hospitalier Lyon Sud; Center Eugene Marquis; IUCT ONCOPOLE
Recruiting
Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Lesions.

Posted: October 20th, 2020, 2:00am GMT

Conditions: Neoplasms, Colorectal
Interventions: Procedure: Endoscopic mucosal resection (EMR); Procedure: Endoscopic submucosal dissection (ESD)
Sponsors: José Carlos Marín Gabriel; Spanish Society of Digestive Endoscopy
Recruiting
GROWing Up With Rare GENEtic Syndromes

Posted: July 9th, 2020, 2:00am GMT

Conditions: Prader-Willi Syndrome; PWS-like Syndrome; Silver Russel Syndrome; Congenital Hypopituitarism; Klinefelter (XXY-)Syndrome; Congenital Adrenal Hyperplasia; XXXXY Syndrome; XXYY Syndrome; XXXX Syndrome (Tetra-X Syndrome); Disorders of Sex Development; Turner Syndrome; 46, XY DSD; Tuberous Sclerosis; Neurofibromatosis; Albright Hereditaire Osteodystrofie; Cornelia de Lange Syndrome; Saethre-Chotzen Syndrome; 17p- Deletiesyndrome; VCF Syndrome; POLR3A Mutatie; Ohdo Syndrome; Jacobsen Syndrome / 11 q Syndrome; Myrhe Syndrome; CHARGE Syndrome; 1q25-32 Deletie; Bardet Biedl Syndrome; Rett Syndrome; 22q11 Deletion Syndrome; Allan-Herndon-Dudley Syndrome; Kallmann Syndrome; Rare Bone Disorders; Noonan Syndrome; Williams-Beuren Syndrome
Interventions: Diagnostic Test: Retrospective file studies
Sponsors: dr. Laura C. G. de Graaff-Herder
Recruiting
Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Posted: June 19th, 2020, 2:00am GMT

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple Myeloma
Interventions: Drug: Trametinib Dimethyl Sulfoxide
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
Neuroendocrine and Adrenal Tumors

Posted: June 16th, 2020, 2:00pm GMT

Conditions: Neuroendocrine Tumors; Adrenal Tumor
Interventions: Other: No intervention
Sponsors: University of Pennsylvania
Not yet recruiting
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer

Posted: June 2nd, 2020, 2:00am GMT

Conditions: Skin Cancer
Interventions: Device: Nevisense 3.0; Device: Dermlite Cam; Procedure: Skin biopsy
Sponsors: NYU Langone Health
Active, not recruiting
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Posted: April 22nd, 2020, 2:00am GMT

Conditions: Adrenocortical Carcinoma
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Posted: April 21st, 2020, 2:00am GMT

Conditions: Polycystic Ovarian Syndrome in Adolescent Females; Vitamin D Deficiency
Interventions: Drug: Vitamin D 4000IU daily; Drug: Placebo
Sponsors: Yale University
Not yet recruiting
Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas

Posted: March 16th, 2020, 2:00am GMT

Conditions: Hypercortisolism
Interventions: Drug: relacorilant; Other: Placebo
Sponsors: Corcept Therapeutics
Recruiting
Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention

Posted: December 10th, 2019, 3:00pm GMT

Condition: Colorectal Cancer
Interventions: Other: virtual technology - high interactive; Other: virtual technology - low interactive; Other: non-colorectal cancer related module
Sponsors: University of Florida; National Cancer Institute (NCI)
Recruiting
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

Posted: November 20th, 2019, 3:00am GMT

Conditions: Chemotherapy-Induced Peripheral Neuropathy; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
Interventions: Behavioral: Whole Body Vibration
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University
Completed
Stereotactic Magnetic Resonance Guided Radiation Therapy

Posted: October 3rd, 2019, 2:00am GMT

Conditions: Pancreas Cancer; Lung Cancer; Renal Cancer; Adrenal Metastases; Prostate Cancer; Liver Metastases; Oligoprogressive Nodal Metastases; Metachronous Nodal Metastases; Synchronous Nodal Metastases; Mesothelioma; Spine Metastases; Brain Metastases; Borderline Resectable Pancreatic Carcinoma
Interventions: Radiation: MR-guided Linac
Sponsors: Dana-Farber Cancer Institute
Suspended
The Registry of Oncology Outcomes Associated With Testing and Treatment

Posted: July 22nd, 2019, 2:00am GMT

Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Biomarker Testing (L); Drug: Systemic Treatment (T); Other: Patient Reported Outcomes (P)
Sponsors: Taproot Health
Recruiting
Erector Spinae Block vs. Placebo Block Study

Posted: June 7th, 2019, 2:00pm GMT

Conditions: Breast Cancer; Nerve Block; Regional Anesthesia; Neuromuscular Blockade
Interventions: Procedure: Erector spinae plane block; Procedure: Placebo Block
Sponsor: Women's College Hospital
Not yet recruiting
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Posted: April 5th, 2019, 2:00am GMT

Conditions: Polycystic Ovary Syndrome
Interventions: Drug: ACTH; Drug: rhCG
Sponsors: University of Virginia
Recruiting
Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

Posted: March 6th, 2019, 3:00am GMT

Conditions: Polycystic Ovary Syndrome; Anovulation; Hyperandrogenism; Insulin Resistance; Glucose Intolerance; Metabolic Complication
Interventions: Other: Placebo; Drug: Inositol
Sponsors: Milton S. Hershey Medical Center; National Center for Complementary and Integrative Health (NCCIH)
Recruiting
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer

Posted: March 5th, 2019, 3:00pm GMT

Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; The Alfred; Beacon Hospital, Ireland; Cancer Trials Ireland; Cancer Research UK Edinburgh Centre; Bon Secours Cork Cancer Centre; UPMC Hillman Cancer Centre; Beatson West of Scotland Cancer Centre; Tom Baker Cancer Centre; Walker Family Cancer Centre; Riverina Cancer Care Centre
Recruiting
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

Posted: February 6th, 2019, 3:00am GMT

Conditions: Cushing Disease
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
SABR for Renal Tumors

Posted: November 20th, 2018, 3:00pm GMT

Condition: Renal Tumor
Intervention: Radiation: Stereotactic Ablative Radiotherapy
Sponsor: University Health Network, Toronto
Recruiting

1 2

← PubMed - Adrenocortical Carcinoma Trial - Adrenocortical Carcinoma →

Rare Cancer News & Clinical Trials » Trial - Adrenal Cancer

Feeds

Trial - Adrenal Cancer (100 unread)

Posted: November 21st, 2023, 3:00am GMT

Posted: November 16th, 2023, 3:00am GMT

Posted: November 15th, 2023, 3:00am GMT

Posted: November 9th, 2023, 3:00am GMT

Posted: October 25th, 2023, 2:00am GMT

Posted: October 19th, 2023, 2:00am GMT

Posted: October 5th, 2023, 2:00am GMT

Posted: October 4th, 2023, 2:00am GMT

Posted: October 4th, 2023, 2:00am GMT

Posted: October 2nd, 2023, 2:00am GMT

Posted: September 27th, 2023, 2:00am GMT

Posted: September 27th, 2023, 2:00am GMT

Posted: September 22nd, 2023, 2:00pm GMT

Posted: September 18th, 2023, 2:00pm GMT

Posted: September 14th, 2023, 2:00am GMT

Posted: September 11th, 2023, 2:00am GMT

Posted: September 8th, 2023, 2:00am GMT

Posted: September 6th, 2023, 2:00pm GMT

Posted: August 28th, 2023, 2:00pm GMT

Posted: August 23rd, 2023, 2:00pm GMT

Posted: August 22nd, 2023, 2:00pm GMT

Posted: August 21st, 2023, 2:00am GMT

Posted: August 14th, 2023, 2:00am GMT

Posted: August 8th, 2023, 2:00pm GMT

Posted: August 7th, 2023, 2:00pm GMT

Posted: August 1st, 2023, 2:00am GMT

Posted: July 19th, 2023, 2:00am GMT

Posted: July 11th, 2023, 2:00pm GMT

Posted: June 15th, 2023, 2:00pm GMT

Posted: June 9th, 2023, 2:00pm GMT

Posted: June 1st, 2023, 2:00pm GMT

Posted: May 23rd, 2023, 2:00pm GMT

Posted: May 2nd, 2023, 2:00pm GMT

Posted: April 28th, 2023, 2:00pm GMT

Posted: April 25th, 2023, 2:00am GMT

Posted: April 18th, 2023, 2:00pm GMT

Posted: April 10th, 2023, 2:00pm GMT

Posted: April 7th, 2023, 2:00am GMT

Posted: March 29th, 2023, 2:00pm GMT

Posted: March 24th, 2023, 2:00pm GMT

Posted: March 24th, 2023, 2:00pm GMT

Posted: March 23rd, 2023, 2:00pm GMT

Posted: March 10th, 2023, 3:00pm GMT

Posted: March 6th, 2023, 3:00pm GMT

Posted: March 6th, 2023, 3:00pm GMT

Posted: March 1st, 2023, 3:00pm GMT

Posted: February 27th, 2023, 3:00pm GMT

Posted: February 24th, 2023, 3:00pm GMT

Posted: February 22nd, 2023, 3:00pm GMT

Posted: January 18th, 2023, 3:00pm GMT

Posted: January 18th, 2023, 3:00am GMT

Posted: December 2nd, 2022, 3:00am GMT

Posted: September 10th, 2022, 2:00am GMT

Posted: July 19th, 2022, 2:00am GMT

Posted: July 13th, 2022, 2:00am GMT

Posted: July 7th, 2022, 2:00pm GMT

Posted: June 29th, 2022, 2:00pm GMT

Posted: May 11th, 2022, 2:00am GMT

Posted: May 10th, 2022, 2:00pm GMT

Posted: April 26th, 2022, 2:00pm GMT

Posted: April 26th, 2022, 2:00pm GMT

Posted: April 1st, 2022, 2:00am GMT

Posted: March 29th, 2022, 2:00am GMT

Posted: February 14th, 2022, 3:00pm GMT

Posted: January 20th, 2022, 3:00pm GMT

Posted: December 21st, 2021, 3:00pm GMT

Posted: December 2nd, 2021, 3:00pm GMT

Posted: November 23rd, 2021, 3:00pm GMT

Posted: September 5th, 2021, 2:00am GMT

Posted: August 19th, 2021, 2:00pm GMT

Posted: August 10th, 2021, 2:00pm GMT

Posted: July 21st, 2021, 2:00pm GMT

Posted: July 19th, 2021, 2:00pm GMT